CORO1A and breast carcinoma: The expression of CORO1A was significantly higher in breast cancer patients than normal controls in subgroup analysis based on female, age, menopause status, disease stage 1–3, nodal metastasis status, and molecular subtypes (all P < 0.05, Fig. 11c).